HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Metformin

WITHDRAWN · PHASE1 · Healthy

The sponsor made a business decision to withdraw the trial.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.